Wanbing Qin
Overview
Explore the profile of Wanbing Qin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin W, Huang J, Zhang M, Xu M, He J, Liu Q
ACS Biomater Sci Eng
. 2024 Sep;
10(10):6078-6096.
PMID: 39226188
Acute kidney injury (AKI) is a disease that is characterized by a rapid decline in renal function and has a relatively high incidence in hospitalized patients. Sepsis, renal hypoperfusion, and...
2.
He J, Qin W, Jiang S, Lin Y, Lin Y, Yang R, et al.
Drug Dev Res
. 2024 Jun;
85(4):e22219.
PMID: 38845211
Sepsis is a life-threatening organ dysfunction that endangers patient lives and is caused by an imbalance in the host defense against infection. Sepsis continues to be a significant cause of...
3.
He J, Lin Y, Cai W, Lin Y, Qin W, Shao Y, et al.
Shock
. 2023 Aug;
60(3):333-344.
PMID: 37548606
Background: The COVID-19 pandemic has posed a disproportionately high threat to the global health system and social stability. COVID-19 damage can lead to hyperinflammation and tissue damage due to a...
4.
Qin W, Quan G, Sun Y, Chen M, Yang P, Feng D, et al.
Theranostics
. 2020 Jul;
10(18):8179-8196.
PMID: 32724465
High aggressiveness and recurrence of melanoma tumors require multiple systemic drug administrations, causing discomfort and severe side effects to the patients. Topical treatment strategies that provide repetitively controllable and precise...
5.
Chen M, Quan G, Wen T, Yang P, Qin W, Mai H, et al.
ACS Appl Mater Interfaces
. 2020 May;
12(29):32259-32269.
PMID: 32406239
In this study, an ingenious core-shell structure microneedle (CSMN) array was designed to synergistically boost robust immune response by the intralesional codelivery of photosensitizer and indoleamine 2,3-dioxygenase (IDO) blockade. Photosensitizer...
6.
Li X, Lu C, Xia W, Quan G, Huang Y, Bai X, et al.
AAPS PharmSciTech
. 2020 Jan;
21(3):78.
PMID: 31970547
Protein drugs were considered to be the first choice to treat many human diseases, but their clinical application was usually limited by their short half-life and lack of validated targeted...
7.
Yang P, Lu C, Qin W, Chen M, Quan G, Liu H, et al.
Acta Biomater
. 2020 Jan;
104:147-157.
PMID: 31904558
Synergistic anti-tumor effect of anti-PD-1/L1 antibody (aPD-1/aPD-L1) and 1-methyl-D,L-tryptophan (1-MT) in melanoma has been well demonstrated, while efficient topical delivery systems are still largely unexplored. Here, a highly drug-concentrated hybrid...
8.
Lin S, Quan G, Hou A, Yang P, Peng T, Gu Y, et al.
J Control Release
. 2019 May;
306:69-82.
PMID: 31145948
A hypertrophic scar (HS) is a cutaneous condition characterized by deposits of excessive amounts of collagen that produces a raised scar, causing physical, psychological, and cosmetic problems for the patient....
9.
Chen H, Wu B, Zhang M, Yang P, Yang B, Qin W, et al.
Drug Deliv Transl Res
. 2018 Oct;
9(1):240-248.
PMID: 30341765
Microneedle arrays have emerged as an alternative method for transdermal drug delivery. Although micromolding using a centrifugation method is widely used to prepare microneedles in laboratory, few researchers were focused...